RAD Technology Medical Systems to Provide VRCC Veterinary Specialty and Emergency Hospital with Standalone Radiotherapy Center

RAD Technology Medical Systems (RAD) is pleased to announce that they will be providing Veterinary Referral Center of Colorado, also know as, VRCC Veterinary Specialty and Emergency Hospital (VRCC) in Sheridan, CO with a veterinary radiotherapy center. This facility will allow VRCC to provide improved radiation therapy treatment to animals with cancer.

RAD’s patented technology and offsite modular construction methods provide their customers with a flexible, high-quality facility solution that is completed ahead of conventional construction.

RAD’s modular radiotherapy center was the perfect solution for the growing VRCC. They were looking for a quick solution that would allow them to upgrade their services in the region. They selected a pre-existing RAD facility that will be updated and expanded to meet all of their specific program needs.

Unlike with conventionally built radiotherapy centers, RAD’s facility and equipment will be able to make Beam within 5-7 days of its arrival on site, and will be ready to treat patients within 30 days of arrival.

This facility originally served as a Temporary Radiotherapy Vault, or RAD Temp, and was previously used by cancer centers from coast to coast, in five states and the District of Columbia, to treat patients while those cancer centers upgraded their radiotherapy equipment.

“We are excited to be entering the Veterinary Market,” said Kenneth Wright, RAD’s Vice President of Sales and Business Development. “The veterinary oncology market is growing and our modular approach is the perfect solution for veterinary offices looking to expand or add radiation treatment to their location.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version